Literature DB >> 24090474

Intractable hiccup caused by spinal cord lesions in demyelination disease.

Xiao-ting Hao1, Lu Wang1, Bo Yan1, Hong-yu Zhou1.   

Abstract

OBJECTIVE: This study aimed to summarize the clinical features of patients who presented intractable hiccup (IH) without brain and medulla oblongata (MO) lesions.
METHOD: This study included six patients who were diagnosed with inflammatory demyelinating myelitis, categorized as neuromyelitis optica (NMO), multiple sclerosis (MS), and myelitis. Patients who presented IH with cervical lesions but without MO lesions were also included. Clinical profiles, laboratory data, and magnetic resonance imaging findings were analyzed.
RESULTS: Three out of six patients were diagnosed with NMO, whereas the remaining three were diagnosed with acute myelitis, recurrent myelities, and MS, respectively. The duration of hiccup was from 2 to 23 days (average = 9.33 ± 8.64 days). Five patients (83.33%, patients 1-5) had long segmental lesions and one had a patchy lesion. None of these patients had any MO lesions. Half of them were successfully treated with high-dose methylprednisolone combined with gamma-aminobutyric acid (GABA) inhibitor.
CONCLUSION: IH occurred in patients without MO lesion. However, the mechanism remained unclear. Immune factors of demyelinating neuropathy stimulated the hiccup reflex arch. Cervical cord lesions may activate the hiccup center. In general, IH can be controlled by IVMP combined with GABA inhibitor. Unilateral phrenic nerve block may elicit no effect.

Entities:  

Mesh:

Year:  2013        PMID: 24090474      PMCID: PMC3831336          DOI: 10.1179/2045772313Y.0000000148

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  14 in total

1.  Why do we hiccup?

Authors:  P J Kahrilas; G Shi
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

2.  Intractable hiccups associated with high-dose intravenous methylprednisolone therapy.

Authors:  B A Baethge; M D Lidsky
Journal:  Ann Intern Med       Date:  1986-01       Impact factor: 25.391

3.  Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica.

Authors:  T Misu; K Fujihara; I Nakashima; S Sato; Y Itoyama
Journal:  Neurology       Date:  2005-11-08       Impact factor: 9.910

Review 4.  Atypical presentations of neuromyelitis optica.

Authors:  Douglas Sato; Kazuo Fujihara
Journal:  Arq Neuropsiquiatr       Date:  2011-10       Impact factor: 1.420

5.  Hoquet diabolique: intractable hiccups as a manifestation of multiple sclerosis.

Authors:  D A McFarling; J O Susac
Journal:  Neurology       Date:  1979-06       Impact factor: 9.910

Review 6.  Hiccups: a treatment review.

Authors:  N L Friedman
Journal:  Pharmacotherapy       Date:  1996 Nov-Dec       Impact factor: 4.705

7.  Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica.

Authors:  S R Hinson; S J Pittock; C F Lucchinetti; S F Roemer; J P Fryer; T J Kryzer; V A Lennon
Journal:  Neurology       Date:  2007-10-10       Impact factor: 9.910

Review 8.  The spectrum of neuromyelitis optica.

Authors:  Dean M Wingerchuk; Vanda A Lennon; Claudia F Lucchinetti; Sean J Pittock; Brian G Weinshenker
Journal:  Lancet Neurol       Date:  2007-09       Impact factor: 44.182

9.  Refractory hiccup: successful treatment with gabapentin.

Authors:  Hortensia Alonso-Navarro; Lluisa Rubio; Félix Javier Jiménez-Jiménez
Journal:  Clin Neuropharmacol       Date:  2007 May-Jun       Impact factor: 1.592

Review 10.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

Authors:  Chris H Polman; Stephen C Reingold; Gilles Edan; Massimo Filippi; Hans-Peter Hartung; Ludwig Kappos; Fred D Lublin; Luanne M Metz; Henry F McFarland; Paul W O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Brian G Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

View more
  3 in total

Review 1.  Intractable Hiccups.

Authors:  Stasia Rouse; Matthew Wodziak
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-22       Impact factor: 5.081

2.  Baclofen for stroke patients with persistent hiccups: a randomized, double-blind, placebo-controlled trial.

Authors:  Cuie Zhang; Ruifen Zhang; Shuangyan Zhang; Meiling Xu; Shuyan Zhang
Journal:  Trials       Date:  2014-07-22       Impact factor: 2.279

3.  Intractable Hiccups due to Isolated Parainfectious Myelitis.

Authors:  Samhita Panda; Diwakar Verma
Journal:  J Neurosci Rural Pract       Date:  2020-03-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.